Hemochromatosis genotypes and risk of 31 disease endpoints: Meta-analyses including 66,000 cases and 226,000 controls
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Hemochromatosis genotypes have been associated with liver disease, diabetes mellitus, heart disease, arthritis, porphyria cutanea tarda, stroke, neurodegenerative disorders, cancer, and venous disease. We performed meta-analyses including 202 studies with 66,263 cases and 226,515 controls to examine associations between hemochromatosis genotypes C282Y/C282Y, C282Y/H63D, C282Y/wild type, H63D/H63D, and H63D/wild type versus wild type/wild type and 9 overall endpoints and 22 endpoint subgroups. We also explored potential sources of heterogeneity. For liver disease, the odds ratio for C282Y/C282Y versus wild type/wild type was 3.9 (99% confidence interval: 1.9–8.1) overall, 11 (3.7–34) for hepatocellular carcinoma, 4.1 (1.2–14) for hepatitis C, and 10 (2.1–53) for nonalcoholic steatohepatitis. For porphyria cutanea tarda, the odds ratios were 48 (24–95) for C282Y/C282Y, 8.1 (3.9–17) for C282Y/H63D, 3.6 (1.8–7.3) for C282Y/wild type, 3.0 (1.6–5.6) for H63D/H63D, and 1.7 (1.0–3.1) for H63D/wild type versus wild type/wild type. Finally, for amyotrophic lateral sclerosis, the odds ratio was 3.9 (1.2–13) for H63D/H63D versus wild type/wild type. These findings were consistent across individual studies. The hemochromatosis genotypes were not associated with risk for diabetes mellitus, heart disease, arthritis, stroke, cancer, or venous disease in the overall analyses; however, the odds ratio for C282Y/C282Y versus wild type/wild type was 3.4 (1.1–11) for diabetes mellitus among North Europeans. Conclusion: In aggregate, clinically ascertained cases who are homozygous for the C282Y mutation are associated with a 4–11–fold risk of liver disease, whereas all 5 hemochromatosis genotypes are associated with a 2–48–fold risk of porphyria cutanea tarda, and H63D/H63D is associated with a 4-fold risk of amyotrophic lateral sclerosis. These results, mainly from case-control studies, cannot necessarily be extrapolated to the general population. (HEPATOLOGY 2007.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Hereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992 · cited 2×
“As many of the studies included in the present meta-analyses reported on only 1 of the 2 polymorphisms, we assessed C282Y/wild type and H63D/wild type in 2 ways: (1) only studies presenting all genotypes were involved (simple heterozygotes) and (2) all studies were included (mixed heterozygotes).”
BackgroundFeder, J. N., Penny, D. M., Irrinki, A., Lee, V. K., Lebrón, J. A., Watson, N., Tsuchihashi, Z., Sigal, E., Bjorkman, P. J., & Schatzman, R. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1472 · Cited by 827
Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
Beutler, E., Felitti, V. J., Koziol, J. A., Ho, N. J., & Gelbart, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07447-0 · Cited by 823
Iron in Nonhemochromatotic Liver Disorders
Alla, V., & Bonkovsky, H. L. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923317 · Cited by 124
Iron Dysregulation and Neurodegeneration: The Molecular Connection
Lee, D. W. (2006) · Molecular Interventions · doi:10.1124/mi.6.2.6 · Cited by 80
Cited by
Puy, H., Gouya, L., & Deybach, J.-C. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61925-5 · Cited by 729
EASL clinical practice guidelines for HFE hemochromatosis
European Association for the Study of the Liver (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.001 · Cited by 587
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Grosse, S. D., Gurrin, L. C., Bertalli, N. A., & Allen, K. J. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.121 · Cited by 76
Current applications of therapeutic phlebotomy.
(2014) · Europe PMC (PubMed Central) · doi:10.2450/2013.0299-12 · Cited by 65
Metadata
- Authors
- Ellervik, C., Birgens, H., Tybjærg-Hansen, A., & Nordestgaard, B. G.
- Venue
- Hepatology
- Published
- 2007-10
- Volume
- 46
- Issue
- 4
- Pages
- 1071-1080
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2023397971
- Cited by
- 152
- References
- 7
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hemochromatosis genotypes and risk of 31 disease endpoints: Meta-analyses including 66,000 cases and 226,000 controls. https://app.cochat.ai/papers/10.1002/hep.21885
- The paper
- Ellervik, C., Birgens, H., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2007). Hemochromatosis genotypes and risk of 31 disease endpoints: Meta-analyses including 66,000 cases and 226,000 controls. Hepatology. https://doi.org/10.1002/hep.21885
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.